Fritextsökning
Innehållstyper
-
Enjoy Stockholm - the capital of Scandinavia
Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and at...
-
Samuel Lagercrantz: Samarbete och samverkan är nyckeln till framgång
Trots att många frågor om covid-19 fortfarande är obesvarade har utvecklingen av läkemedel och vaccin gått otroligt snabbt, skriver Samuel Lagercrantz i en ledare.
-
Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
-
Hey there Summer Eriksson......
.....biomedical analysist at Akademsika sjukhuset in Uppsala. Why are you here at Biotech Forum and Scanlab?
-
Biden utser coronateam – hans rådgivare kritiserar Tegnell
USA:s nya president Joe Biden intar en helt ny hållning i bekämpningen av covid-19 än sin företrädare. Hans rådgivare Andy Slavitt kritiserade nyligen Anders Te...
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
-
Vaccinkandidat används i pågående utbrott
Ebolavaccin under utveckling skickas till Demokratiska republiken Kongo.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Nya resultat om immunförsvarets reaktion vid svår covid-19
Forskare har identifierat flera celltyper som är centrala vid immunförsvarets reaktion vid covid-19.
-
Pfizer överväger nya bud
Obama-administrationens nya skatteregler hämmar inte bolagets köplust.
-
Varnar för Astra-preparat
FDA går ut med ännu en varning för läkemedelsklassen SGLT2-hämmare.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Multilabel plate readers with luminescence capability
The Enspire Multilabel Plate Reader platform from Perkin Elmer now features sensitive luminescence detection. The new detection capability is primarily aimed at...
-
Bioreactor features disposable sensors
The Biostat Cultibag STR line of bioreactors from Sartorius-Stedim features disposable components to reduce risk of contamination.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Analytisk kemi nytt ben för Recipharm
CDMO Recipharm lanserar en fristående tjänst inom analytisk kemi.
-
Norwegian entrance in EU technology network
The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
BREAKING